Processa Pharmaceuticals doses first subject in Phase II breast cancer trial
The goal is to assess the safety, efficacy and determine optimal dosing regimens of NGC-Cap.
NIH selects Emergex’s T cell vaccine for trials under Project NextGen
Qnovia set to trial smoking cessation inhaler in the US
SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
UroGen begins subject dosing in Phase III bladder cancer drug trial
Exscientia outline robot and AI use in drug discovery workflow
Barinthus Bio completes enrolment in hepatitis B and prostate cancer vaccine trials
Analysis
View More
Themes
View MorePerimeter completes enrolment for AI-assisted breast imaging trial
The primary endpoint results from the trial are expected by the end of the year and will be used to support an FDA approval for the OCT B-Series device.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule
Moderna blamed after children offered £1,500 to take part in Covid-19 trial
Wesper sleep platform reduces nerve stimulation titration time by 45%
Alio starts trial to expand label for remote monitoring device